1. Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma
   Serena Cecchetti et al, 2015, PLOS ONE CrossRef
2. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review)
   IGOR BRYUKHOVETSKIY et al, 2016, Oncology Reports CrossRef
3. Identification of a panel of genes as a prognostic biomarker for glioblastoma
   Fengfei Wang et al, 2018, EBioMedicine CrossRef
4. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells
   Shibnath Ghatak et al, 2021, International Journal of Molecular Sciences CrossRef
5. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance
   Zhujun Xu, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
6. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells
   Wen-Shin Song et al, 2016, Journal of the Chinese Medical Association CrossRef
7. Molecular mechanisms of drug resistance of glial tumor of brain. Part 2: Proliferation, angiogenesis, metastasis and recurrency
   Alexander N. Chernov et al, 2022, Medical academic journal CrossRef